To sign up for our e-mail newsletter or print publications, fill out the information below and click Subscribe.
Vice President, Medical, Clinical & Regulatory Affairs of bioTheranostics, Inc.
Two-pronged attack on chemotherapy-resistant leukemia cells
An Early Look at Research From the 2016 ASCO Annual Meeting
Drug against breast cancer is also highly potent against a frequent form of leukaemia
Improving natural killer cancer therapy: Study